On August 27th, 2024, Sichuan Xieli Pharmaceutical Co., Ltd. (hereinafter referred to as "Sichuan Xieli Pharmaceutical") shone brilliantly at the 2024 CPHI International Active Pharmaceutical Ingredients Exhibition held in Seoul, South Korea. As a leading enterprise in the active pharmaceutical ingredient (API) industry, Xieli Pharmaceutical not only displayed an innovative product line, but also successfully drew the attention of numerous international customers and partners with its green technology and global strategy, showcasing the company's new pinnacle in exploring the international market.

Innovation Leader, Quality Building Trust

At this CPHI exhibition, Sichuan Xieli Pharmaceutical presented API products encompassing multiple fields, including cardiovascular, anti-tumor, and anti-infection, showcasing the company's technical superiority and R&D prowess in several key domains. Each API undergoes rigorous quality control to guarantee high purity and stability, meeting the stringent requirements of global pharmaceutical companies.

"Our products are not only the crystallization of technology, but also our commitment to quality." The booth of Xieli attracted representatives from pharmaceutical companies around the world, the company's product quality and innovation ability was highly praised.

Green Pharmaceutical, Environmental Protection

It is worth mentioning that Xieli Pharmaceutical also placed great emphasis on showcasing its green chemical processes and eco-friendly production lines at this exhibition, reflecting the company's strong commitment to sustainable development. By reducing energy consumption and waste emissions, Xieli Pharmaceutical has adopted a more environmentally friendly production approach in the manufacturing process, making a contribution to the global green pharmaceutical industry.
"Environmental protection in production is not only an industry trend but also our corporate social responsibility," said the person in charge of Xieli Pharmaceutical.

International Cooperation, Exploring the Global Market

Driven by the trend of globalization, Sichuan Xieli Pharmaceutical not only maintains a leading edge in technology but also accelerates the exploration of the international market through diversified cooperation models. At this CPHI exhibition in South Korea, Xieli Pharmaceutical reached preliminary cooperation intentions with many internationally renowned pharmaceutical companies, further enhancing the company's influence in the global market.
"Through this exhibition, we hope to collaborate with more international partners to jointly promote the development of the global health industry," said the company's marketing director. Xieli Pharmaceutical's global layout is steadily progressing, and it will continue to be committed to providing high-quality API solutions for the global pharmaceutical industry in the future.

Expecting Future, Keep Innovating

With the continuous expansion of the global pharmaceutical market, Sichuan Xieli Pharmaceutical will continue to focus on technological innovation and product optimization to provide more high-quality and reliable API solutions for global customers. This appearance at CPHI Korea not only marks a solid step for Xieli Pharmaceutical in the international market, but also lays the foundation for further development in the future.

Sichuan Xieli Pharmaceutical looks forward to working with more global partners in the future to jointly contribute to the cause of human health!